Scarica l'app Stockscreener
22.66
11.02%
2.255
Forte Biosciences Inc Borsa (FBRX) Ultime notizie
FRTX to Acquire Crinetics Pharmaceuticals for $10 Billion - GuruFocus
RSU vesting boosts holdings at Forte Biosciences (NASDAQ: FBRX) - Stock Titan
FBRXForte Biosciences Inc Options - Finviz
(FBRX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Enterprise value to EBIT forward of Forte Biosciences, Inc. – NASDAQ:FBRX - TradingView
Forte Biosciences, Inc.(NasdaqCM:FBRX) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell 2500 Growth Benchmark - marketscreener.com
Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell 2000 Index - marketscreener.com
Forte Biosciences, Inc.(NasdaqCM:FBRX) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell 2000 Growth Benchmark - marketscreener.com
Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell 3000E Growth Benchmark - marketscreener.com
Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell Small Cap Completeness Index - marketscreener.com
FBRX Q1 2026 Earnings: EPS Misses Estimates, No Revenue Reported, Stock Gains 2.15%Earnings Deceleration Risk - dars.gov.et
Forte Biosciences Inc (FBRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Forte Biosciences Inc (FBRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Forte Biosciences Inc (FBRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Forte Biosciences Inc (FBRX) Institutional Confidence - TradingKey
Forte Biosciences Inc (FBRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Forte Biosciences (FBRX) CFO receives 22,000 stock options grant - Stock Titan
Forte Biosciences (FBRX) awards 500,000 stock options to insider Wagner - Stock Titan
Forte Biosciences Inc (FBRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Forte Biosciences Inc (FBRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Forte Biosciences Inc (FBRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Forte Biosciences (FBRX) Dips Nearly 5%: Testing Key Support at $16.29Revenue Weighted - newsline.com
One Forte Biosciences Insider Raised Stake By 30% In Previous Year - Yahoo Finance
[EFFECT] Forte Biosciences, Inc. SEC Filing - Stock Titan
FBRX Q1 2026 Earnings: Wider-than-Expected Loss as Biotech Continues DevelopmentMargin Guidance - newsline.com
Trading Systems Reacting to (FBRX) Volatility - Stock Traders Daily
Forte Biosciences (FBRX) Gains 5%: Support and Resistance Levels in FocusWave Extension - dars.gov.et
Millennium Group (FBRX) reports shared control of 1,062,182 shares - Stock Titan
Forte Biosciences | SCHEDULE 13G: Others - Moomoo
Forte Biosciences (FBRX) Edges Lower Amid Sector Volatility, Key Support HoldsSmart Money Flow Stocks - newsline.com
Number of shareholders of Forte Biosciences Inc. – GETTEX:37T - TradingView
Forte Biosciences (FBRX) Slips 1% as Stock Consolidates Between Key Support and ResistanceTrend Continuation Trade - newsline.com
Forte Biosciences (NASDAQ: FBRX) files $500M shelf to sell securities - Stock Titan
Forte Biosciences Shareholders Approve Directors and Governance Items - TipRanks
Forte Biosciences (NASDAQ: FBRX) director receives 18,353 RSU equity award - Stock Titan
Forte Biosciences (NASDAQ: FBRX) files $500M shelf; highlights FB102 clinical wins - Stock Titan
Forte Biosciences (FBRX) director awarded 18,353 restricted stock units in equity grant - Stock Titan
Forte Biosciences (FBRX) director granted 18,353 RSUs in equity award - Stock Titan
Forte Biosciences (FBRX) director awarded 18,353 RSUs vesting after 2026 meeting - Stock Titan
Director at Forte Biosciences (NASDAQ: FBRX) awarded 18,353 RSUs as equity grant - Stock Titan
Forte Biosciences (FBRX) awards 18,353 RSUs to director Steven Kornfeld - Stock Titan
Forte Biosciences (FBRX) stockholders approve amended 2021 equity incentive plan - Stock Titan
FBRX Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues Clinical Progress - newsline.com
Forte Biosciences (FBRX) price target increased by 19.72% to 65.02 - MSN
Forte Biosciences Slides As Insider Purchases Lose Another US$70k - simplywall.st
Forte Biosciences Inc stock (US34960P1012): shares slip after recent Q1 loss and high volatility - AD HOC NEWS
FBRX Q1 2026 Earnings: Pre-Revenue Biotech Reports Narrow EPS Miss Amid Ongoing DevelopmentSurprise Factor Analysis - newsline.com
Forte Biosciences Q1 2026 Earnings: Pre-revenue Biotech Misses EPS Estimates; Stock Dips on Narrower Loss MissTech Earnings Analysis - The Legal Advocate
FBRX Q1 2026 Earnings: Wider-than-Expected Loss Reflects Pre-Revenue Biotech RealityLive Trade Sharing - Newser
Forte Biosciences stock (US34960P1012): Q1 update keeps focus on skin disease pipeline - AD HOC NEWS
(FBRX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Forte Biosciences Inc stock (US34960P1012): clinical pivot and cash focus keep biotech investors ale - AD HOC NEWS
Forte Biosciences stock (US34960P1012): volatile biotech after recent sell-off tests investor nerves - AD HOC NEWS
Forte Biosciences stock (US34960P1012): New 13G filings highlight major holders - AD HOC NEWS
2.18%
2.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):